Bafna Pharmaceuticals Ltd
company logo

Bafna Pharmaceuticals Ltd

Pharmaceuticals
Small Cap

-

0 (0%)


Bafna Pharmaceuticals Ltd Performance

-

-

-

-


-

-

-

-

-

Bafna Pharmaceuticals Ltd Fundamentals

220Cr

0

4.30

0.70

0

0%

21.61

i buttonClick here to know more about Fundamentals

Bafna Pharmaceuticals Ltd Financials

Bafna Pharmaceuticals Ltd Financialsright-arrow

Bafna Pharmaceuticals Ltd Shareholding Pattern

Bafna Pharmaceuticals Ltd Delivery and Volume

About Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products. The first manufacturing unit w

-

1995

BAFNAPH

NameDesignation
Babulal Kamlesh KumarNon-Exec. & Independent Dir.
Shanmugam HemalathaChairperson / Executive Director
Akilapriya Chandrashekar RajuNon-Exec & Non-Independent Dir
Palamadai Krishnan SundaresanNon-Exec. & Independent Dir.
Ravichandran ChitraNon-Exec. & Independent Dir.
Upendar Mekala ReddyNon Executive Director
Krishna YeachuriIndependent Director
Vinayak Dinesh DendukuriWhole-time Director
A MohanachandranCompany Sec. & Compli. Officer
News and Events...

Similar Stocks

What's Trending

Bafna Pharmaceuticals Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Bafna Pharmaceuticals Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Bafna Pharmaceuticals Ltd's share price is ₹84.38 as of 2024-07-25.
Bafna Pharmaceuticals Ltd's P/E ratio is - times as of 2024-07-25.
Bafna Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 4.3, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Bafna Pharmaceuticals Ltd's market capitalization is ₹220 Cr as on 2024-07-25.
The current financial records of Bafna Pharmaceuticals Ltd show a 8.86% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Bafna Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹87.31, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Bafna Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Bafna Pharmaceuticals Ltd's 52-week high and low as of 2024-07-25 are ₹87.5 and ₹83.5, respectively.